Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 40


Pyrolytic Kinetics of Polystyrene Particle in Nitrogen Atmosphere: Particle Size Effects and Application of Distributed Activation Energy Method.

Jiang L, Yang XR, Gao X, Xu Q, Das O, Sun JH, Kuzman MK.

Polymers (Basel). 2020 Feb 12;12(2). pii: E421. doi: 10.3390/polym12020421.


Experimental study of the effect of typical halides on pyrolysis of ammonium nitrate using model reconstruction.

Cao HQ, Duan QL, Chai H, Li XX, Sun JH.

J Hazard Mater. 2020 Feb 15;384:121297. doi: 10.1016/j.jhazmat.2019.121297. Epub 2019 Sep 24.


An experimental and theoretical study of optimized selection and model reconstruction for ammonium nitrate pyrolysis.

Cao HQ, Jiang L, Duan QL, Zhang D, Chen HD, Sun JH.

J Hazard Mater. 2019 Feb 15;364:539-547. doi: 10.1016/j.jhazmat.2018.10.048. Epub 2018 Oct 23.


Sample width and thickness effects on upward flame spread over PMMA surface.

Jiang L, He JJ, Sun JH.

J Hazard Mater. 2018 Jan 15;342:114-120. doi: 10.1016/j.jhazmat.2017.08.022. Epub 2017 Aug 12.


Experimental study on thermal hazard of tributyl phosphate-nitric acid mixtures using micro calorimeter technique.

Sun Q, Jiang L, Gong L, Sun JH.

J Hazard Mater. 2016 Aug 15;314:230-236. doi: 10.1016/j.jhazmat.2016.04.030. Epub 2016 Apr 14.


Synergistic Activity of Combined NS5A Inhibitors.

O'Boyle DR 2nd, Nower PT, Gao M, Fridell R, Wang C, Hewawasam P, Lopez O, Tu Y, Meanwell NA, Belema M, Roberts SB, Cockett M, Sun JH.

Antimicrob Agents Chemother. 2015 Dec 28;60(3):1573-83. doi: 10.1128/AAC.02639-15.


Resensitizing daclatasvir-resistant hepatitis C variants by allosteric modulation of NS5A.

Sun JH, O'Boyle DR 2nd, Fridell RA, Langley DR, Wang C, Roberts SB, Nower P, Johnson BM, Moulin F, Nophsker MJ, Wang YK, Liu M, Rigat K, Tu Y, Hewawasam P, Kadow J, Meanwell NA, Cockett M, Lemm JA, Kramer M, Belema M, Gao M.

Nature. 2015 Nov 12;527(7577):245-8. doi: 10.1038/nature15711. Epub 2015 Nov 4.


[Therapeutic Efficacy of Multigly-Cosidorum Tripterygium Combined with rhIL-11 for Immune Thrombocytopenia].

Yu XQ, Chen HM, Sun JH, Luo M, Lu YL.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2015 Oct;23(5):1400-3. doi: 10.7534/j.issn.1009-2137.2015.05.034. Chinese.


Comparison of daclatasvir resistance barriers on NS5A from hepatitis C virus genotypes 1 to 6: implications for cross-genotype activity.

Wang C, Jia L, O'Boyle DR 2nd, Sun JH, Rigat K, Valera L, Nower P, Huang X, Kienzle B, Roberts S, Gao M, Fridell RA.

Antimicrob Agents Chemother. 2014 Sep;58(9):5155-63. doi: 10.1128/AAC.02788-14. Epub 2014 Jun 16.


Trait impulsivity and impaired prefrontal impulse inhibition function in adolescents with internet gaming addiction revealed by a Go/No-Go fMRI study.

Ding WN, Sun JH, Sun YW, Chen X, Zhou Y, Zhuang ZG, Li L, Zhang Y, Xu JR, Du YS.

Behav Brain Funct. 2014 May 30;10:20. doi: 10.1186/1744-9081-10-20.


Discovery and development of hepatitis C virus NS5A replication complex inhibitors.

Belema M, Lopez OD, Bender JA, Romine JL, St Laurent DR, Langley DR, Lemm JA, O'Boyle DR 2nd, Sun JH, Wang C, Fridell RA, Meanwell NA.

J Med Chem. 2014 Mar 13;57(5):1643-72. doi: 10.1021/jm401793m. Epub 2014 Feb 3.


Characterizations of HCV NS5A replication complex inhibitors.

O'Boyle Ii DR, Sun JH, Nower PT, Lemm JA, Fridell RA, Wang C, Romine JL, Belema M, Nguyen VN, Laurent DR, Serrano-Wu M, Snyder LB, Meanwell NA, Langley DR, Gao M.

Virology. 2013 Sep;444(1-2):343-54. doi: 10.1016/j.virol.2013.06.032. Epub 2013 Jul 27.


HCV NS5A replication complex inhibitors. Part 5: discovery of potent and pan-genotypic glycinamide cap derivatives.

Belema M, Nguyen VN, St Laurent DR, Lopez OD, Qiu Y, Good AC, Nower PT, Valera L, O'Boyle DR 2nd, Sun JH, Liu M, Fridell RA, Lemm JA, Gao M, Knipe JO, Meanwell NA, Snyder LB.

Bioorg Med Chem Lett. 2013 Aug 1;23(15):4428-35. doi: 10.1016/j.bmcl.2013.05.040. Epub 2013 May 23.


A 96-well based analysis of replicon elimination with the HCV NS5A replication complex inhibitor daclatasvir.

O'Boyle DR 2nd, Nower PT, Sun JH, Fridell R, Wang C, Valera L, Gao M.

J Virol Methods. 2013 Oct;193(1):68-76. doi: 10.1016/j.jviromet.2013.04.024. Epub 2013 May 14.


HCV NS5A replication complex inhibitors. Part 4. Optimization for genotype 1a replicon inhibitory activity.

St Laurent DR, Serrano-Wu MH, Belema M, Ding M, Fang H, Gao M, Goodrich JT, Krause RG, Lemm JA, Liu M, Lopez OD, Nguyen VN, Nower PT, O'Boyle DR 2nd, Pearce BC, Romine JL, Valera L, Sun JH, Wang YK, Yang F, Yang X, Meanwell NA, Snyder LB.

J Med Chem. 2014 Mar 13;57(5):1976-94. doi: 10.1021/jm301796k. Epub 2013 Apr 10.


Altered default network resting-state functional connectivity in adolescents with Internet gaming addiction.

Ding WN, Sun JH, Sun YW, Zhou Y, Li L, Xu JR, Du YS.

PLoS One. 2013;8(3):e59902. doi: 10.1371/journal.pone.0059902. Epub 2013 Mar 26.


Reply: To PMID 22234905.

Sun JH, Gao M, Roberts S, Fridell R.

Hepatology. 2013 May;57(5):2087-8. doi: 10.1002/hep.26381. No abstract available.


Persistence of resistant variants in hepatitis C virus-infected patients treated with the NS5A replication complex inhibitor daclatasvir.

Wang C, Sun JH, O'Boyle DR 2nd, Nower P, Valera L, Roberts S, Fridell RA, Gao M.

Antimicrob Agents Chemother. 2013 May;57(5):2054-65. doi: 10.1128/AAC.02494-12. Epub 2013 Feb 12.


HCV NS5A replication complex inhibitors. Part 3: discovery of potent analogs with distinct core topologies.

Lopez OD, Nguyen VN, St Laurent DR, Belema M, Serrano-Wu MH, Goodrich JT, Yang F, Qiu Y, Ripka AS, Nower PT, Valera L, Liu M, O'Boyle DR 2nd, Sun JH, Fridell RA, Lemm JA, Gao M, Good AC, Meanwell NA, Snyder LB.

Bioorg Med Chem Lett. 2013 Feb 1;23(3):779-84. doi: 10.1016/j.bmcl.2012.11.086. Epub 2012 Dec 3.


Neuropsychological study of patients with obsessive-compulsive disorder and their parents in China: searching for potential endophenotypes.

Li B, Sun JH, Li T, Yang YC.

Neurosci Bull. 2012 Oct;28(5):475-82. doi: 10.1007/s12264-012-1262-2. Epub 2012 Aug 30.

Supplemental Content

Loading ...
Support Center